Alembic Pharmaceuticals

Historical price data

Alembic Pharmaceuticals is a vertically integrated, publicly listed Indian pharmaceutical company with a century-long legacy. It operates through two main segments: Generics and Branded Generics, with a robust manufacturing infrastructure and a growing international footprint, particularly in the US market. The company is strategically focused on complex generics, biosimilars, and specialty products to drive future growth, supported by significant R&D investments.

Vertically integrated model with expertise in complex generic formulation development (inhalers, transdermals, injectables), biosimilars development, and cost-effective API synthesis.

3 drugs in pipeline

Alembic competes directly with large Indian pharmaceutical companies (Sun Pharma, Dr. Reddy's, Cipla, Lupin) and global generic firms (Teva, Viatris) in the international generics space. Its differentiation strategy focuses on developing complex generics and biosimilars to move away from highly commoditized, competitive segments.